ARTICLE | Management Tracks
Lyndra names Adam Sayer president and CEO
Plus: Martin Olin becomes CEO of Swarm, and updates from Totus, Nmdp and Vortex
January 29, 2025 1:41 AM UTC
Lyndra Therapeutics Inc., which is developing long-acting oral therapies, named Adam Sayer president, CEO and board member. Sayer succeeds Jessica Ballinger and was chief transformation officer at Envision Healthcare.
Swarm Oncology Ltd. named Martin Olin CEO. Olin was CEO of Bergenbio ASA and Symphogen A/S. The U.K. biotech was co-founded by CSO John Campbell and Delin Ventures to develop T cell therapies for solid tumors. ...